Page last updated: 2024-09-03

ro 32-0432 and Cardiac Output, Low

ro 32-0432 has been researched along with Cardiac Output, Low in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carr, AN; Dorn, GW; Hahn, H; Hambleton, M; Hewett, TE; Kimball, TF; Klevitsky, R; Koch, WJ; Kuhn, MC; Molkentin, JD; Pleger, ST	1

Other Studies

1 other study(ies) available for ro 32-0432 and Cardiac Output, Low

Article	Year
Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation, 2006, Aug-08, Volume: 114, Issue:6 Topics: Animals; Calcium; Cardiac Output, Low; Cardiomyopathy, Dilated; DNA; Enzyme Activation; Female; Gene Expression Regulation; Genetic Therapy; Indoles; Male; Mice; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardium; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction	2006

Article

Year

Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure.

Circulation, 2006, Aug-08, Volume: 114, Issue:6

Topics: Animals; Calcium; Cardiac Output, Low; Cardiomyopathy, Dilated; DNA; Enzyme Activation; Female; Gene Expression Regulation; Genetic Therapy; Indoles; Male; Mice; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardium; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction

2006